SUTRO BIOPHARMA INC

Profile

Company Names

SUTRO BIOPHARMA INC

Addresses

310 UTAH AVE., SUITE 150, SOUTH SAN FRANCISCO, CA 94080

310 UTAH AVE., #150, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

650-392-8412

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$85,382,349.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2018-05-24 
$85,382,349.00 
$85,382,351.00 
$2.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
DYBBS 
DIRECTOR
VERSARTIS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  SAMSARA BIOCAPITAL, L.P.   |  SUTRO BIOPHARMA INC   |  NKARTA, INC.   |  565 SPV I, L.P.   |  LEVO THERAPEUTICS, INC.   |  DELFI DIAGNOSTICS, INC.   |  ABCURO, INC.   |  SAMSARA OPPORTUNITY FUND, L.P.
JOHN 
G. 
FREUND 
DIRECTOR
ADVION, INC.   |  XENOPORT INC   |  PROTEON THERAPEUTICS INC   |  SI-BONE, INC.   |  SUTRO BIOPHARMA INC   |  TETRAPHASE PHARMACEUTICALS INC
DANIEL 
 
JANNEY 
DIRECTOR
DISCOVERX CORP   |  VIROBAY INC   |  PHENOMIX CORP   |  ESPERION THERAPEUTICS, INC.   |  VIVEVE MEDICAL, INC.   |  EVOLVE BIOSYSTEMS, INC.   |  SUTRO BIOPHARMA INC
BRYAN 
 
LAWLIS 
DIRECTOR
ABSCI, LLC   |  SUTRO BIOPHARMA INC
VIRGIL 
BRYAN 
LAWLIS 
DIRECTOR
SUTRO BIOPHARMA INC
JOSEPH 
 
LOBACKI 
DIRECTOR
SUTRO BIOPHARMA INC
WILLIAM 
J. 
NEWELL 
EXECUTIVE OFFICER, DIRECTOR
SYMIC HOLDINGS, LLC   |  SUTRO BIOPHARMA INC
DANIEL 
 
PETREE 
DIRECTOR
BIOCEPT INC   |  CORNERSTONE TREASURY STRATEGIES FUND, LLC   |  SUTRO BIOPHARMA INC   |  LIPIDIO PHARMACEUTICALS INC.
MICHAEL 
 
ROSS 
DIRECTOR
CERVILENZ INC   |  JUVARIS BIO THERAPEUTICS INC   |  IKANO THERAPEUTICS INC.   |  ADIMAB, INC.   |  SV LIFE SCIENCES FUND V LP   |  LINK MEDICINE CORP   |  CATABASIS PHARMACEUTICALS INC   |  SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.   |  ARSANIS, INC.   |  BALANCE HEALTH CORP   |  ABCAM PLC   |  ADIMAB, LLC   |  AVITIDE, INC.   |  OPHTHOTECH CORP.   |  THESAN PHARMACEUTICALS, INC.   |  SV LIFE SCIENCES FUND VI, L.P.   |  DECIPHERA PHARMACEUTICALS, LLC   |  DEMENTIA DISCOVERY LP   |  AMERICLEAN HOLDINGS LLC   |  SV LIFE SCIENCES FUND VI STRATEGIC PARTNERS, L.P.   |  FRESCO FOODS, INC.   |  SUTRO BIOPHARMA INC   |  RIBOMETRIX, INC.   |  JASON RYAN   |  NICE RECOVERY SYSTEMS LLC   |  THERINI BIO, INC.   |  MAINE CRISP COMPANY, LLC   |  JOSEPH VENTURES ALLIUM I LLC, SERIES A   |  XILIO THERAPEUTICS, INC.   |  JOSEPH VENTURES ALLIUM I LLC, SERIES C   |  SV LIFE SCIENCES FUND IV CF, L.P.   |  ANDOVIA INC.   |  TREX HOLDINGS INC.   |  DUALITAS THERAPEUTICS, INC.
ARMEN 
 
SHANAFELT 
DIRECTOR
HEMAQUEST PHARMACEUTICALS   |  HEMAQUEST PHARMACEUTICALS, INC.   |  PROTAGONIST THERAPEUTICS INC   |  AEGLEA BIOTHERAPEUTICS HOLDINGS, LLC   |  AILERON THERAPEUTICS INC   |  SYMIC HOLDINGS, LLC   |  AEGLEA BIOTHERAPEUTICS, INC.   |  SUTRO BIOPHARMA INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-08-08
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-05-24 
2018-06-06
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-05-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#